Discussion: ‘Long-term postmenopausal hormone therapy and endometrial cancer risk’ by Doherty et al

In the roundtable that follows, clinicians discuss a study published in this issue of the Journal in light of its methodology, relevance to practice, and implications for future research. Article discussed:Doherty JA, Cushing-Haugen KL, Saltzman BS, et al. Long-term use of postmenopausal estrogen and progestin hormone therapies and risk of endometrial cancer. Am J Obstet Gynecol 2007;197:139.e1-139.e7.